Trimodal GSTT1 and GSTM1 genotyping assay by real-time PCR

Area of Science:

• Pharmacogenomics
• Molecular Biology
• Biochemistry

Background:

• Glutathione S-transferase (GST) enzymes, encoded by GSTT1 and GSTM1 genes, play a role in detoxification.
• Null alleles in GSTT1 and GSTM1 genes lead to a lack of enzyme activity, influencing individual susceptibility.
• Previous studies often grouped GST genotypes, limiting detailed risk assessment.

Purpose of the Study:

• To develop and validate TaqMan real-time quantitative PCR assays for discriminating all three genotypes of GSTT1 and GSTM1.
• To enable a more precise evaluation of cancer risk associated with specific GST genotypes.

Main Methods:

• Development of TaqMan real-time quantitative PCR assays for GSTT1 and GSTM1.
• Utilized the albumin gene (ALB) as a reference for normalization.
• Discriminated between homozygous wild-type (*1/1), heterozygous (*1/0), and homozygous null (*0/0) genotypes.

Main Results:

• The assays successfully discriminated between the three genotypes for both GSTT1 and GSTM1.
• Observed frequencies for GSTT1*0/0 (27.6%) and GSTM1*0/0 (55.2%) were consistent with published data.
• Genotype frequencies were in agreement with Hardy-Weinberg distributions, indicating assay reliability.

Conclusions:

• The developed real-time PCR assays provide unambiguous discrimination of GSTT1 and GSTM1 genotypes.
• These assays are valuable tools for future epidemiological studies assessing cancer risk.
• Precise genotype identification allows for a more nuanced understanding of GST enzyme activity and its relation to disease.